Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

45.23
+1.633.74%
Post-market: 45.250.0200+0.04%17:40 EDT
Volume:966.53K
Turnover:43.80M
Market Cap:3.64B
PE:32.44
High:46.17
Open:43.71
Low:43.50
Close:43.60
52wk High:60.91
52wk Low:29.46
Shares:80.39M
Float Shares:78.97M
Volume Ratio:0.74
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.39
EPS(LYR):0.8200
ROE:8.77%
ROA:4.09%
PB:2.62
PE(LYR):55.16

Loading ...

Cathie Wood’s ARK Investment buys 115.5K shares of Veracyte today

TIPRANKS
·
Oct 06

Should Trial Data Validation Require Action From Veracyte (VCYT) Investors?

Simply Wall St.
·
Oct 05

U.S. Stocks on the MOVE-Snowflake, Cboe, Oracle

Reuters
·
Sep 29

US Stocks on the MOVE-Veracyte, Staar Surgical, Corning

Reuters
·
Sep 29

Veracyte announces new findings from Phase III NRG/RTOG 0815 trial

TIPRANKS
·
Sep 29

Veracyte Gains on Data Supporting Use of Prostate Cancer Test to Guide Treatment Decisions

Reuters
·
Sep 29

Veracyte Decipher Prostate Test Predicts Benefit of Adding Hormone Therapy to Radiation in Phase III Trial Analysis

Reuters
·
Sep 29

Phase Iii Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation

THOMSON REUTERS
·
Sep 29

Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026

GlobeNewswire
·
Sep 26

Veracyte Global Chief Commercial Officer John Leite Sells 4,015 Shares for $160,600

Reuters
·
Sep 23

Analysts Have Conflicting Sentiments on These Healthcare Companies: Veracyte (VCYT), IQVIA Holdings (IQV) and Chemed (CHE)

TIPRANKS
·
Sep 17

Veracyte Director Jens Holstein Disposes of USD 204,747 Common Shares

Reuters
·
Sep 17

Veracyte Adds Another Stream to Bladder Franchise, UBS Says

MT Newswires Live
·
Sep 15

Veracyte Price Target Maintained with a $66.00/Share by Freedom Capital Markets

Dow Jones
·
Sep 15

Veracyte Completes Convergent Genomics Acquisition to Expand Urology

TIPRANKS
·
Sep 15

Veracyte Buys Convergent Genomics

MT Newswires Live
·
Sep 15

Veracyte acquires Convergent Genomics for $150M in cash upfront

TIPRANKS
·
Sep 15

Veracyte Acquires Convergent Genomics, Expanding Its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform

THOMSON REUTERS
·
Sep 15

Veracyte, - Acquisition Includes $150 Mln Upfront Cash and up to $30 Mln Milestone Payments

THOMSON REUTERS
·
Sep 15

Veracyte, - Expects to Commercialize Initial Uroamp Test in Late 2028

THOMSON REUTERS
·
Sep 15